Liste des patients
traités
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

Lp.
Source
Type de source
Diagnostic
Domaine médical
Année d'application
Thérapie
Pays
Âge du bénéficiaire
Tout
Tout
Tout
Tout
Tout
Tout
Tout
Tout
1
Cord Tissue
Allogeneic - Related
Chronic renal disease
Endocrinology
2025
Experimental Therapy
Romania
50
2
Cord Tissue
Allogeneic - Related
Autism
Neurology
2025
Experimental Therapy
Romania
6
3
Cord Tissue
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
6
4
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2025
Experimental Therapy
Poland
57
5
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
3
6
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
3
7
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
2
8
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
5
9
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
11
10
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
54
11
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
78
12
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
6
13
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
58
14
Cord Tissue
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
5
15
Cord Tissue
Allogeneic - Related
Autism
Neurology
2025
Experimental Therapy
Romania
5
16
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
4
17
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
7
18
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
7
19
Cord Blood
Allogeneic - Related
Thalassemia Major
Hematology
2025
Standard Therapy
Turkey
5
20
Cord Blood
Autologous
Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
2
21
Cord Blood
Allogeneic - Related
Thalassemia Major
Hematology
2025
Standard Therapy
Turkey
6
22
Cord Blood
Allogeneic - Related
Cerebral Palsy
Neurology
2025
Experimental Therapy
Portugal
1
23
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
5
24
Cord Blood
Allogeneic
Acute lymphoblastic leukemia
Hematology
2025
Standard Therapy
Poland
13
25
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Poland
5
26
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Poland
7
27
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
Poland
71
28
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
United Kingdom
72
29
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
47
30
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Ukraine
43
31
Bone Marrow Family
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Italy
49
32
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
51
33
Bone Marrow Family
Allogeneic
Philadelphia - positive Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Germany
61
34
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
58
35
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
NETHERLANDS
63
36
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
65
37
Bone Marrow Family
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
France
63
38
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Poland
68
39
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
France
71
40
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Russia
51
41
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
62
42
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Czechia
54
43
Bone Marrow
Allogeneic
Aplastic Anemia
Hematology
2025
Standard Therapy
Spain
15
44
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Norway
55
45
Bone Marrow
Allogeneic
Inherited Immune System Disorder
Hematology
2025
Standard Therapy
France
3
46
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
USA
7
47
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Ukraine
36
48
Bone Marrow
Allogeneic
Inherited Immune System Disorder
Hematology
2025
Standard Therapy
France
10
49
Bone Marrow
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
USA
76
50
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
39
51
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
South Africa
6
52
Bone Marrow
Allogeneic
Wiskott-Aldrich syndrome
Hematology
2025
Standard Therapy
Turkey
6
53
Bone Marrow
Allogeneic
Combined immnunodeficiency
Hematology
2025
Standard Therapy
Ukraine
3
54
Bone Marrow
Allogeneic
Chronic Granulomatous Disease
Hematology
2025
Standard Therapy
Poland
3
55
Bone Marrow
Allogeneic
Mixed Phenotype Acute Leukemia
Hematology
2025
Standard Therapy
Poland
13
56
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
7
57
Bone Marrow
Allogeneic
B-cell precursor Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
56
58
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
43
59
Bone Marrow
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Poland
19
60
Bone Marrow
Allogeneic
Very Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
12
61
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
5
62
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
10
63
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
6
64
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
44
65
Bone Marrow
Allogeneic
Paroxysmal Nocturnal Hemoglobinuria
Hematology
2025
Standard Therapy
Poland
25
66
Bone Marrow
Allogeneic
Juvenile Myelomonocytic Leukemia
Hematology
2025
Standard Therapy
Poland
4
67
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
USA
21
68
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Italy
12
69
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Hungary
10
70
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Czechia
68
71
Bone Marrow
Allogeneic
Adrenoleukodystrophy
Hematology
2025
Standard Therapy
Poland
53
72
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Germany
4
73
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
France
4
74
Bone Marrow
Allogeneic
Paroxysmal Nocturnal Hemoglobinuria
Hematology
2025
Standard Therapy
Norway
18
75
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
58
76
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
34
77
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Italy
61
78
Apheresis
Allogeneic
Myelodysplastic Syndrome/Myeloproliferative neoplasm
Hematology
2025
Standard Therapy
NETHERLANDS
62
79
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Austria
68
80
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
70
81
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
66
82
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
77
83
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Ukraine
12
84
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
58
85
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
67
86
Apheresis
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
4
87
Apheresis
Allogeneic
Myelofibrosis Myeloid Metaplasia
Hematology
2025
Standard Therapy
USA
73
88
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
56
89
Apheresis
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Italy
50
90
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
39
91
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Lithuania
43
92
Apheresis
Allogeneic
Chronic Myelomonocytic Leukemia
Hematology
2025
Standard Therapy
Poland
66
93
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2025
Standard Therapy
USA
61
94
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Austria
55
95
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Italy
69
96
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Denmark
67
97
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
United Kingdom
75
98
Apheresis
Allogeneic
T - cell Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
24
99
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Belgium
68
100
Apheresis
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Ukraine
42
Pagevon77
100 Rangées
Chargement